INTEGRA LIFESCIENCES HOLDINGS CORP Excess Tax Benefit from Share-based Compensation, Financing Activities
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of -$6.16 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-04-29.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2019-04-29
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, financing activities for the quarter ending 2019-03-31 was -$6.16M.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, financing activities for the quarter ending 2018-12-31 was -$406.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, financing activities for the quarter ending 2018-09-30 was -$175.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, financing activities for the quarter ending 2018-06-30 was -$464.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, financing activities for fiscal 2018 was -$7.82M.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, financing activities for fiscal 2017 was -$7.12M.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, financing activities for fiscal 2016 was -$4.85M.
- INTEGRA LIFESCIENCES HOLDINGS CORP excess tax benefit from share-based compensation, financing activities for fiscal 2015 was -$6.58M.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month as first filed | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | -$6.16M 10-Q · filed 2019-04-29 | -$6.56M derived: sum of 2 quarters · filed 2019-04-29 | -$6.74M derived: sum of 3 quarters · filed 2019-04-29 | -$7.20M derived: sum of 4 quarters · filed 2019-04-29 | ||||
| 2018-12-31 | -$406.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$581.00K derived: sum of 2 quarters · filed 2019-02-26 | -$1.04M derived: sum of 3 quarters · filed 2019-02-26 | -$7.82M 10-K · filed 2019-02-26 | ||||
| 2018-09-30 | -$175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$639.00K derived: sum of 2 quarters · filed 2018-11-01 | -$7.42M 10-Q · filed 2018-11-01 | -$7.78M derived: sum of 4 quarters · filed 2019-04-29 | ||||
| 2018-06-30 | -$464.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | -$7.24M 10-Q · filed 2018-07-26 | -$7.60M derived: sum of 3 quarters · filed 2019-04-29 | -$7.87M derived: sum of 4 quarters · filed 2019-04-29 | ||||
| 2018-03-31 | -$6.78M 10-Q · filed 2019-04-29 | -$7.14M derived: sum of 2 quarters · filed 2019-04-29 | -$7.40M derived: sum of 3 quarters · filed 2019-04-29 | -$7.77M derived: sum of 4 quarters · filed 2019-04-29 | ||||
| 2017-12-31 | -$360.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$625.00K derived: sum of 2 quarters · filed 2019-02-26 | -$995.00K derived: sum of 3 quarters · filed 2019-02-26 | -$7.12M 10-K · filed 2019-02-26 | ||||
| 2017-09-30 | -$265.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$635.00K derived: sum of 2 quarters · filed 2018-11-01 | -$6.76M 10-Q · filed 2018-11-01 | -$7.05M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | -$370.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | -$6.50M 10-Q · filed 2018-07-26 | -$6.78M derived: sum of 3 quarters · filed 2019-02-26 | -$7.08M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | -$6.13M 10-Q · filed 2018-04-26 | -$6.41M derived: sum of 2 quarters · filed 2019-02-26 | -$6.71M derived: sum of 3 quarters · filed 2019-02-26 | -$6.93M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | -$284.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$582.00K derived: sum of 2 quarters · filed 2019-02-26 | -$800.00K derived: sum of 3 quarters · filed 2019-02-26 | -$4.85M 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | -$298.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | -$516.00K derived: sum of 2 quarters · filed 2017-10-26 | -$4.57M 10-Q · filed 2017-10-26 | -$4.70M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-06-30 | -$218.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | -$4.27M 10-Q · filed 2017-07-26 | -$4.40M derived: sum of 3 quarters · filed 2018-03-01 | -$4.49M derived: sum of 4 quarters · filed 2018-03-01 | ||||
| 2016-03-31 | -$4.05M 10-Q · filed 2017-04-26 | $1.81M 10-Q · filed 2016-04-27 | -$4.18M derived: sum of 2 quarters · filed 2018-03-01 | -$4.27M derived: sum of 3 quarters · filed 2018-03-01 | -$11.75M derived: sum of 4 quarters · filed 2018-03-01 | |||
| 2015-12-31 | -$134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$221.00K derived: sum of 2 quarters · filed 2018-03-01 | -$7.70M derived: sum of 3 quarters · filed 2018-03-01 | -$6.58M 10-K · filed 2018-03-01 | $3.79M 10-K · filed 2016-02-26 | |||
| 2015-09-30 | -$87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$7.57M derived: sum of 2 quarters · filed 2016-10-28 | -$6.45M 10-Q · filed 2016-10-28 | $3.68M 10-Q · filed 2015-11-04 | -$10.37M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-06-30 | -$7.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-28 | -$6.36M 10-Q · filed 2016-07-28 | $3.50M 10-Q · filed 2015-07-31 | -$10.28M derived: sum of 3 quarters · filed 2017-02-23 | -$10.24M derived: sum of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | $1.12M 10-Q · filed 2016-04-27 | -$2.80M derived: sum of 2 quarters · filed 2017-02-23 | -$2.76M derived: sum of 3 quarters · filed 2017-02-23 | -$2.14M derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | -$3.92M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$3.88M derived: sum of 2 quarters · filed 2017-02-23 | -$3.26M derived: sum of 3 quarters · filed 2017-02-23 | -$2.72M 10-K · filed 2017-02-23 | $1.38M 10-K · filed 2015-02-27 | |||
| 2014-09-30 | $43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | $666.00K derived: sum of 2 quarters · filed 2015-11-04 | $1.21M 10-Q · filed 2015-11-04 | $1.34M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-06-30 | $623.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-31 | $1.16M 10-Q · filed 2015-07-31 | $1.29M derived: sum of 3 quarters · filed 2016-02-26 | $1.33M derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2014-03-31 | $541.00K 10-Q · filed 2015-05-01 | $671.00K derived: sum of 2 quarters · filed 2016-02-26 | $709.00K derived: sum of 3 quarters · filed 2016-02-26 | $788.00K derived: sum of 4 quarters · filed 2016-02-26 | ||||
| 2013-12-31 | $130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26 | $168.00K derived: sum of 2 quarters · filed 2016-02-26 | $247.00K derived: sum of 3 quarters · filed 2016-02-26 | $270.00K 10-K · filed 2016-02-26 | ||||
| 2013-09-30 | $38.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $117.00K derived: sum of 2 quarters · filed 2014-11-07 | $140.00K 10-Q · filed 2014-11-07 | $3.34M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $102.00K 10-Q · filed 2014-08-05 | $3.30M derived: sum of 3 quarters · filed 2015-02-27 | $3.32M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $23.00K 10-Q · filed 2014-05-01 | $3.23M derived: sum of 2 quarters · filed 2015-02-27 | $3.24M derived: sum of 3 quarters · filed 2015-02-27 | $3.65M derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2012-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $3.22M derived: sum of 2 quarters · filed 2015-02-27 | $3.63M derived: sum of 3 quarters · filed 2015-02-27 | $3.63M 10-K · filed 2015-02-27 | ||||
| 2012-09-30 | $14.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-10-30 | $429.00K derived: sum of 2 quarters · filed 2013-10-30 | $432.00K 10-Q · filed 2013-10-30 | $436.00K derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-06-30 | $415.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2013-08-02 | $418.00K 10-Q/A · filed 2013-08-02 | $422.00K derived: sum of 3 quarters · filed 2014-06-20 | $488.00K derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2012-03-31 | $3.00K 10-Q · filed 2013-05-02 | $7.00K derived: sum of 2 quarters · filed 2014-06-20 | $73.00K derived: sum of 3 quarters · filed 2014-06-20 | $798.00K derived: sum of 4 quarters · filed 2014-06-20 | ||||
| 2011-12-31 | $4.00K derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $70.00K derived: sum of 2 quarters · filed 2014-06-20 | $795.00K derived: sum of 3 quarters · filed 2014-06-20 | $848.00K 8-K · filed 2014-06-20 | ||||
| 2011-09-30 | $66.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $791.00K derived: sum of 2 quarters · filed 2012-10-24 | $844.00K 10-Q · filed 2012-10-24 | $949.00K derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-06-30 | $725.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31 | $778.00K 10-Q · filed 2012-07-31 | $883.00K derived: sum of 3 quarters · filed 2013-02-26 | $884.00K derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2011-03-31 | $53.00K 10-Q · filed 2012-04-26 | $158.00K derived: sum of 2 quarters · filed 2013-02-26 | $159.00K derived: sum of 3 quarters · filed 2013-02-26 | $721.00K derived: sum of 4 quarters · filed 2013-02-26 | ||||
| 2010-12-31 | $105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $106.00K derived: sum of 2 quarters · filed 2013-02-26 | $668.00K derived: sum of 3 quarters · filed 2013-02-26 | $3.58M 10-K · filed 2013-02-26 | ||||
| 2010-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-31 | $563.00K derived: sum of 2 quarters · filed 2011-10-31 | $3.48M 10-Q · filed 2011-10-31 | $3.48M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-06-30 | $562.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-01 | $3.47M 10-Q · filed 2011-08-01 | $3.48M derived: sum of 3 quarters · filed 2012-02-27 | $3.49M derived: sum of 4 quarters · filed 2012-02-27 | ||||
| 2010-03-31 | $2.91M 10-Q · filed 2011-04-28 | $2.92M derived: sum of 2 quarters · filed 2012-02-27 | $2.92M derived: sum of 3 quarters · filed 2012-02-27 | |||||
| 2009-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-27 | $13.00K derived: sum of 2 quarters · filed 2012-02-27 | $20.00K 10-K · filed 2012-02-27 | |||||
| 2009-09-30 | $7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-28 | $14.00K 10-Q · filed 2010-10-28 | ||||||
| 2009-06-30 | $7.00K 10-Q · filed 2010-07-29 | |||||||
| 2008-12-31 | $1.59M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |